155 related articles for article (PubMed ID: 9378968)
1. Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis.
Daniel PT; Kroidl A; Cayeux S; Bargou R; Blankenstein T; Dörken B
J Immunol; 1997 Oct; 159(8):3808-15. PubMed ID: 9378968
[TBL] [Abstract][Full Text] [Related]
2. B7.1 on human carcinomas: costimulation of T cells and enhanced tumor-induced T-cell death.
Lang S; Atarashi Y; Nishioka Y; Stanson J; Meidenbauer N; Whiteside TL
Cell Immunol; 2000 May; 201(2):132-43. PubMed ID: 10831322
[TBL] [Abstract][Full Text] [Related]
3. Costimulation of tumor-reactive CD4+ and CD8+ T lymphocytes by B7, a natural ligand for CD28, can be used to treat established mouse melanoma.
Li Y; McGowan P; Hellström I; Hellström KE; Chen L
J Immunol; 1994 Jul; 153(1):421-8. PubMed ID: 7515929
[TBL] [Abstract][Full Text] [Related]
4. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
[TBL] [Abstract][Full Text] [Related]
5. Monocytes provide a novel costimulatory signal to T cells that is not mediated by the CD28/B7 interaction.
Johnson JG; Jenkins MK
J Immunol; 1994 Jan; 152(2):429-37. PubMed ID: 7506722
[TBL] [Abstract][Full Text] [Related]
6. The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo.
Sigal LJ; Reiser H; Rock KL
J Immunol; 1998 Sep; 161(6):2740-5. PubMed ID: 9743331
[TBL] [Abstract][Full Text] [Related]
7. B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptor.
Chan AK; Goedegebuure PS; von Bernstorff W; Carritte AL; Chung M; Stewart RA; Montgomery L; Spanjaard RA; McKenzie AB; Eberlein TJ
Surgery; 2000 Mar; 127(3):342-50. PubMed ID: 10715992
[TBL] [Abstract][Full Text] [Related]
8. Fas ligand (CD95L) and B7 expression on dendritic cells provide counter-regulatory signals for T cell survival and proliferation.
Lu L; Qian S; Hershberger PA; Rudert WA; Lynch DH; Thomson AW
J Immunol; 1997 Jun; 158(12):5676-84. PubMed ID: 9190916
[TBL] [Abstract][Full Text] [Related]
9. Human melanoma-reactive CD4+ and CD8+ CTL clones resist Fas ligand-induced apoptosis and use Fas/Fas ligand-independent mechanisms for tumor killing.
Rivoltini L; Radrizzani M; Accornero P; Squarcina P; Chiodoni C; Mazzocchi A; Castelli C; Tarsini P; Viggiano V; Belli F; Colombo MP; Parmiani G
J Immunol; 1998 Aug; 161(3):1220-30. PubMed ID: 9686582
[TBL] [Abstract][Full Text] [Related]
10. Requirements for CD28-dependent T cell-mediated cytotoxicity.
Azuma M; Cayabyab M; Phillips JH; Lanier LL
J Immunol; 1993 Mar; 150(6):2091-101. PubMed ID: 8383716
[TBL] [Abstract][Full Text] [Related]
11. Fas involvement in cytotoxicity mediated by human NK cells.
Montel AH; Bochan MR; Hobbs JA; Lynch DH; Brahmi Z
Cell Immunol; 1995 Dec; 166(2):236-46. PubMed ID: 7497525
[TBL] [Abstract][Full Text] [Related]
12. Induction of melanoma antigen-specific cytotoxic T lymphocytes in vitro by stimulation with B7-expressing human melanoma cell lines.
Fenton RG; Turcovski-Corrales SM; Taub DD
J Immunother; 1998 Mar; 21(2):95-108. PubMed ID: 9551360
[TBL] [Abstract][Full Text] [Related]
13. The role of the antigen-presenting cell in Fas-mediated direct and bystander killing: potential in vivo function of Fas in experimental allergic encephalomyelitis.
Thilenius AR; Sabelko-Downes KA; Russell JH
J Immunol; 1999 Jan; 162(2):643-50. PubMed ID: 9916681
[TBL] [Abstract][Full Text] [Related]
14. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
Dong H; Strome SE; Salomao DR; Tamura H; Hirano F; Flies DB; Roche PC; Lu J; Zhu G; Tamada K; Lennon VA; Celis E; Chen L
Nat Med; 2002 Aug; 8(8):793-800. PubMed ID: 12091876
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells are resistant to apoptosis through the Fas (CD95/APO-1) pathway.
Ashany D; Savir A; Bhardwaj N; Elkon KB
J Immunol; 1999 Nov; 163(10):5303-11. PubMed ID: 10553053
[TBL] [Abstract][Full Text] [Related]
16. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
[TBL] [Abstract][Full Text] [Related]
17. Newcastle disease virus infection induces B7-1/B7-2-independent T-cell costimulatory activity in human melanoma cells.
Termeer CC; Schirrmacher V; Bröcker EB; Becker JC
Cancer Gene Ther; 2000 Feb; 7(2):316-23. PubMed ID: 10770642
[TBL] [Abstract][Full Text] [Related]
18. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling.
Gati A; Guerra N; Gaudin C; Da Rocha S; Escudier B; Lécluse Y; Bettaieb A; Chouaib S; Caignard A
Cancer Res; 2003 Nov; 63(21):7475-82. PubMed ID: 14612548
[TBL] [Abstract][Full Text] [Related]
19. Strong TCR ligation without costimulation causes rapid onset of Fas-dependent apoptosis of naive murine CD4+ T cells.
Kishimoto H; Sprent J
J Immunol; 1999 Aug; 163(4):1817-26. PubMed ID: 10438914
[TBL] [Abstract][Full Text] [Related]
20. The role of apoptosis in normal ontogenesis and solid human neoplasms.
Kaiser HE; Bodey B
In Vivo; 2000; 14(6):789-803. PubMed ID: 11204498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
